Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in CRBP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,130,766
+$1,276,263 QoQ
Shares Held
333,415
+46.3% QoQ
Ownership
1.80%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CRBP Over Time

Shares Held

Position Value (USD)

Derivatives in CRBP

reported options exposure · as of Mar 31, 2026
CallValue
$675,141
CallShares
71,900
PutValue
$122,070
PutShares
13,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. CRBP ranks #76 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRBP

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $675,141 71,900
2026-03-31 $122,070 13,000
2026-03-31 $3,130,766 333,415
2025-12-31 $1,854,503 227,826
2025-09-30 $875,961 69,246
2025-09-30 $2,465,485 194,900
2025-09-30 $164,450 13,000
2025-06-30 $298,990 43,332
2025-03-31 $96,737 18,218
2024-12-31 $578,200 49,000
2024-12-31 $543,980 46,100
2024-12-31 $351,805 29,814
2024-09-30 $635,610 30,810
2024-09-30 $2,661,270 129,000
2024-09-30 $2,219,788 107,600
2024-06-30 $264,169 5,838
2024-06-30 $837,125 18,500
2024-06-30 $923,100 20,400
2024-03-31 $1,730,484 44,100
2024-03-31 $1,926,684 49,100
2023-12-31 $213,212 35,300
2023-09-30 $237,922 35,300
2023-06-30 $278,320 35,500
2023-03-31 $258,085 35,500